Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BG | Common Stock | Options Exercise | $635K | +8.67K | +25.75% | $73.28 | 42.3K | May 2, 2022 | Direct | |
transaction | BG | Common Stock | Options Exercise | $391K | +7.8K | +18.43% | $50.07 | 50.1K | May 2, 2022 | Direct | |
transaction | BG | Common Stock | Options Exercise | $648K | +8K | +15.96% | $81.00 | 58.1K | May 2, 2022 | Direct | |
transaction | BG | Common Stock | Options Exercise | $631K | +8.3K | +14.28% | $75.99 | 66.4K | May 2, 2022 | Direct | |
transaction | BG | Common Stock | Options Exercise | $617K | +11.9K | +17.92% | $51.89 | 78.3K | May 2, 2022 | Direct | |
transaction | BG | Common Stock | Sale | -$5.14M | -44.7K | -57.03% | $114.98 | 33.7K | May 2, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -8.67K | -100% | $0.00* | 0 | May 2, 2022 | Common Stock | 8.67K | $73.28 | Direct | F2 |
transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -7.8K | -100% | $0.00* | 0 | May 2, 2022 | Common Stock | 7.8K | $50.07 | Direct | F3 |
transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -8K | -100% | $0.00* | 0 | May 2, 2022 | Common Stock | 8K | $81.00 | Direct | F4 |
transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -8.3K | -100% | $0.00* | 0 | May 2, 2022 | Common Stock | 8.3K | $75.99 | Direct | F5 |
transaction | BG | Stock Options (Right to buy) | Options Exercise | $0 | -11.9K | -100% | $0.00* | 0 | May 2, 2022 | Common Stock | 11.9K | $51.89 | Direct | F6 |
Id | Content |
---|---|
F1 | This transaction was executed in multiple trades at prices ranging from $114.62 to $115.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Limited, any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote. |
F2 | This option is exercisable in three equal installments beginning on October 1, 2016. |
F3 | This option is exercisable in three equal annual installments beginning on March 1, 2017. |
F4 | This option is exercisable in three equal annual installments beginning on March 8, 2018. |
F5 | This option is exercisable in three equal annual installments beginning on February 28, 2019. |
F6 | This option is exercisable in three equal annual installments beginning on March 12, 2020. |